In mouse models of colon cancer, activation of PPARγ by the TZD troglitazone increased the frequency and size of colon tumors in both C57BL/6J-APCMin/+ mice [58, 59] and wild-type C57BL/6J mice [60]. Here, PPARG is linked to colonic neoplasm.